4//SEC Filing
HILL NANCY LOUISE 4
Accession 0001209191-20-045396
CIK 0001478320other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 9:00 PM ET
Size
11.2 KB
Accession
0001209191-20-045396
Insider Transaction Report
Form 4
HILL NANCY LOUISE
Sr Vice President, Operations
Transactions
- Exercise/Conversion
Common Stock
2020-08-03$0.84/sh+1,600$1,344→ 11,600 total - Sale
Common Stock
2020-08-03$37.37/sh−1,600$59,792→ 10,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-08-03−1,600→ 99,000 totalExercise: $0.84Exp: 2023-11-03→ Common Stock (1,600 underlying)
Holdings
- 500(indirect: By Ryan Hill (son))
Common Stock
- 300(indirect: By Connor Hill (son))
Common Stock
- 400(indirect: By Brandon Hill (son))
Common Stock
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
- [F3]The option is fully vested and exercisable.
Documents
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001780790
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 9:00 PM ET
- Size
- 11.2 KB